NasdaqCM - Nasdaq Real Time Price • USD
Avenue Therapeutics, Inc. (ATXI)
As of 3:12 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-9,451.0000
-9,451.0000
-7,596.0000
-3,750.0000
-4,613.0000
Investing Cash Flow
-3,000.0000
-3,000.0000
--
--
-1,000.0000
Financing Cash Flow
7,526.0000
7,526.0000
10,541.0000
4,381.0000
--
End Cash Position
1,783.0000
1,783.0000
6,708.0000
3,763.0000
3,132.0000
Capital Expenditure
-3,000.0000
-3,000.0000
--
--
-1,000.0000
Issuance of Capital Stock
7,525.0000
7,525.0000
11,497.0000
5,044.0000
--
Repurchase of Capital Stock
--
--
-1,104.0000
--
--
Free Cash Flow
-12,451.0000
-12,451.0000
-7,596.0000
-3,750.0000
-5,613.0000
12/31/2020 - 6/27/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FBIO Fortress Biotech, Inc.
1.7900
+2.29%
MBIO Mustang Bio, Inc.
0.3400
0.00%
FWBI First Wave BioPharma, Inc.
2.9700
-1.66%
NRBO NeuroBo Pharmaceuticals, Inc.
3.0800
-1.28%
RNAZ TransCode Therapeutics, Inc.
0.4596
+0.15%
NBY NovaBay Pharmaceuticals, Inc.
0.0766
+5.66%
APVO Aptevo Therapeutics Inc.
0.7499
+5.62%
SPRC SciSparc Ltd.
1.2250
+0.41%
GLMD Galmed Pharmaceuticals Ltd.
0.3641
+0.11%
CKPT Checkpoint Therapeutics, Inc.
1.4450
-0.34%